|
Virbac - Comparative Business Analysis Snapshot
Business Description
Virbac. The Group's principal activities are the research, development, manufacture and distribution of veterinary drugs including antibiotics, anti-parasitic drugs, vaccines and dermatological drugs dedicated to animal health care. Their activities are carried out in the following sectors: Pets, Food Producing Animals and other related activities. The Group operates under the brand names Rilexin, Humigel, Novifit, Vet Aquadent, Tenotryl, Megaderm and Anxitan. The Group has operations accross the globe. In 2008, the Group acquired Pharmalett and Schering ranges.
Competitor Analysis
This analysis compares Virbac with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
